-
SSRI Drugs Can Increase Risk of Gastrointestinal Bleeding
Increased Risk of Acute Gastrointestinal Bleeding When Taking Both SSRIs and NSAIDs Long-term use of selective serotonin re-uptake inhibitors, or SSRIs, increases the risk of gastrointestinal bleeding to a degree similar to that caused…
-
FDA Advisory Panel Wants To Review Agency’s Drug-safety Monitoring Efforts
Concern Over FDA’s Handling of Serious Side Effects Issues, Including Recent Drug Recalls Involving Vioxx and Bextra Members of an FDA advisory panel have voted unanimously in favor of having the federal agency provide…
-
Natrecor “Dear Doctor” Letter Seeks to Address Recent Safety Concerns
Letter Includes New Natrecor Label Revised in April 2005 Natrecor is a treatment, administered by injection, for patients with acutely decompensated congestive heart failure (ADHF) with dyspnea. Recent reports in medical journals have raised…
-
Medication Errors in Hospitals Involve Pharmacy-dispensing Errors in Estimated 10-20% of Incidents
Drug Name Confusion is a Common Cause of Drug-related Errors A medication error is generally defined as a deviation from the prescription drug order written by the prescribing physician on the patient’s chart. In…
-
Toxic Epidermal Necrolysis (TEN) is Usually Due to Adverse Drug Reaction
Patients with Toxic Epidermal Necrolysis (TEN) Often Have Fatal Outcome Toxic epidermal necrolysis (TEN) is an infrequent, yet often fatal, severe systemic and cutaneous disease that is most often the result of an adverse…
-
FDA Revises Their Web Site for Easier Use by Patients Looking for Prescription Drug Safety Information
New "Core Page" Provides a Gateway to FDA Drug Safety Information The FDA has begun a revision its web site in order to give patients easier access to all FDA information for a specific…
